AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Create a link to this page

Copy and paste this link tag into your Web page or blog:

<a href="http://www.accessmylibrary.com/coms2/summary_0286-26257186_ITM" title="Facts and information about Gilead's Hepsera approved for hepatitis B.(Gilead Sciences Inc.)">Gilead's Hepsera approved for hepatitis B.(Gilead Sciences Inc.)</a>

Close Set up an RSS feed that alerts you when new articles from BioWorld Week are available.

Frequently asked questions about RSS feeds

Gilead's Hepsera approved for hepatitis B.(Gilead Sciences Inc.)

BioWorld Week

| September 30, 2002 | COPYRIGHT 2003 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

Less than two months after an advisory panel unanimously recommended approval of Gilead Sciences Inc.'s Hepsera (adefovir dipivoxil) for chronic hepatitis B, the FDA has given its expected nod and the company planned to ship the drug last week -- with a price tag that was higher than some analysts had forecast. "We've spoken to several advocates and they think the price is fair," said Erin Edgley, public affairs…

View articles courtesy of your local library

Related articles from newspapers, magazines, journals, and more


GILEAD SCIENCES INC. Foster City, California; Drug Maker's Tight Focus Gives It...: Magazine article from: Investor's Business Daily September 30, 2004 700+ words
...twice, shame on me. Analysts seem to be saying that about Gilead Sciences. For two straight quarters, the company has run roughshod...s results surprise management, too? No officer of the Foster City, Calif.-based firm would comment. As for analysts...


Gilead Sciences Inc., of Foster City, Calif., received early termination of the...: Newspaper article from: BioWorld International April 13, 2005 700+ words
Gilead Sciences Inc., of Foster City, Calif., received early termination of the required waiting period with respect to the licensing agreement announced on March...


Gilead Sciences Inc., of Foster City, Calif., and Aspen Pharmacare, of...: Newspaper article from: BioWorld International April 27, 2005 700+ words
Gilead Sciences Inc., of Foster City, Calif., and Aspen Pharmacare, of Johannesburg, South Africa, signed a letter of intent to enter a nonexclusive licensing...


GILEAD SCIENCES INC. Foster City, California; Drug Maker Prepares For Tough...: Magazine article from: Investor's Business Daily August 8, 2003 700+ words
...out new uses for existing drugs. That's not the case at Gilead Sciences Inc. Over the past 20 months it has won Food and Drug Administration...Two days later, Reuters reported that the FDA warned Gilead Sciences to stop making exaggerated claims about the drug. In a...


GILEAD SCIENCES INC. /Foster City, California Hot Competition Has Drug Maker...: Magazine article from: Investor's Business Daily September 10, 2001 700+ words
...decides to graze in other pastures. What can you do but find a new boyfriend to replace him? That's what's happening at Gilead Sciences Inc., a drug maker specializing in infectious diseases. Its best selling drug, AmBisome, has been a reliable sales...


GILEAD SCIENCES INC. Foster City, California Biotech Sees Diversity As Good...: Magazine article from: Investor's Business Daily April 23, 2002 700+ words
...fatal. Over the years, various drugs have surfaced to treat hepatitis B. Among the latest is Adefovir Dipivoxil, made by Gilead Sciences Inc. The biotech recently finished gathering data from its clinical trials, and in March applied for regulatory review...


GILEAD SCIENCES INC. /Foster City, California As Competition Rises, Firm Eyes...: Magazine article from: Investor's Business Daily January 4, 2001 700+ words
Byline: Gloria Lau Investor's Business Daily For years, biotech company Gilead Sciences Inc. has been developing new drugs to lessen its reliance on AmBisome, a treatment for fungal infections that generated 94...


German speciality chemicals company Degussa has sold Raylo Chemicals, part of...: Magazine article from: Chemistry and Industry Eisberg, Neil June 19, 2006 700+ words
...its exclusive synthesis and catalysts business unit located in Edmonton, Canada, to Gilead Sciences, the biopharmaceutical company based in Foster City, California. The 115m [pounds sterling] ($146m) deal, expected to be completed...


Avian Flu Sparks Row Over Drug; Gilead Sciences; Foster City, Calif....: Magazine article from: Investor's Business Daily October 24, 2005 700+ words
Byline: Peter Benesh Earnings shmearnings. Yes, Gilead had a record quarter, largely on the strength of its AIDS medicine Truvada. But the hot news is Tamiflu. Gilead scientists created the anti-viral drug touted as the best hope against avian flu. In 1996, Gilead licensed Tamiflu to Roche. Now


US biopharmaceutical firm Gilead Sciences, which also has operations in...: Magazine article from: Chemistry and Industry Eisberg, Neil February 23, 2009 700+ words
US biopharmaceutical firm Gilead Sciences, which also has operations in Australia and Europe, is expanding with the acquisition of the site adjacent to its Foster City, California, headquarters, from Electronics for Imaging, a specialist in digital printing.

For more facts and information, see all results

Source: HighBeam Research, Gilead's Hepsera approved for hepatitis B.(Gilead Sciences Inc.)

The AccessMyLibrary advertising network includes: